ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

CMMB Chemomab Therapeutics Ltd

0,948
0,0981 (11,54%)
18 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Chemomab Therapeutics Ltd CMMB NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,0981 11,54% 0,948 19:00:06
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,9441 0,90 1,035 0,948 0,8499
mais cotações »

Notícias Recentes

Data Hora Fonte Título
18/06/202408:00GLOBEChemomab Therapeutics Announces New Publications Reinforcing..
06/06/202408:00GLOBEChemomab Therapeutics Presents Data Supporting the Clinical..
17/05/202408:00GLOBEChemomab Therapeutics to Participate in Upcoming Scientific..
09/05/202408:00GLOBEChemomab Therapeutics Announces First Quarter 2024 Financial..
08/05/202408:00GLOBEChemomab Therapeutics Granted 180-Day Extension by Nasdaq to..
02/05/202408:00GLOBEChemomab Therapeutics to Present at 2024 Aegis Virtual..
24/04/202408:00GLOBEChemomab Therapeutics to Report First Quarter 2024 Financial..
18/04/202408:00GLOBEChemomab Reports New Peer-Reviewed Publication Reinforcing..
02/04/202408:00GLOBEChemomab to Host Virtual Key Opinion Leader Webinar on..
25/03/202408:06GLOBEChemomab Awarded New European Patent for CM-101, Its..
07/03/202409:00PRNUSChemomab Therapeutics Announces Year End and Fourth Quarter..
05/03/202409:00PRNUSChemomab Therapeutics to Participate in Leerink Global..
20/02/202411:20APSBiotech Shares Massively Bid Up Before Opening Bell
20/02/202409:00PRNUSChemomab Awarded New Patents for CM-101, Its First-in Class..
14/02/202409:00PRNUSChemomab Therapeutics to Report Fourth Quarter and Full Year..
05/02/202409:00PRNUSChemomab Therapeutics to Participate in Upcoming Investor..
30/01/202409:00PRNUSChemomab Therapeutics Announces New Publication Reinforcing..
03/01/202409:00PRNUSChemomab Announces Completion of Patient Enrollment in..
16/11/202309:00PRNUSChemomab Presentation at ACR Convergence 2023 Provides..
15/11/202309:00PRNUSChemomab Therapeutics Receives FDA Fast Track Designation..
13/11/202310:00PRNUSChemomab Presents New Clinical Data Supporting CM-101's..
09/11/202310:00PRNUSChemomab Therapeutics Announces Third Quarter 2023 Financial..
06/11/202318:15PRNUSChemomab Therapeutics Discloses Receipt of Nasdaq Notice..
30/10/202308:00PRNUSChemomab Therapeutics to Report Third Quarter 2023 Financial..
26/10/202308:00PRNUSChemomab Therapeutics to Present at Upcoming Scientific..
28/09/202308:00PRNUSChemomab Therapeutics to Present Its CM-101 Clinical Program..
29/08/202308:00PRNUSChemomab Therapeutics to Present at the H.C. Wainwright 25th..
14/08/202309:00PRNUSChemomab Therapeutics Announces Second Quarter 2023..
28/06/202308:00PRNUSChemomab Therapeutics Announces Publication in JCI Insight..
26/06/202308:00PRNUSChemomab Therapeutics Presents Data Reinforcing the Clinical..
21/06/202308:00PRNUSChemomab Therapeutics Reports Positive Data from Secondary..

Seu Histórico Recente

Delayed Upgrade Clock